お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
962561

膵臓がん診断の世界市場:規模・現状・予測 (2020~2026年)

Global Pancreatic Cancer Diagnostic Market Size, Status and Forecast 2020-2026

出版日: | 発行: QYResearch | ページ情報: 英文 106 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.58円
膵臓がん診断の世界市場:規模・現状・予測 (2020~2026年)
出版日: 2021年04月02日
発行: QYResearch
ページ情報: 英文 106 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の膵臓がん診断の市場規模は、2019年には51億2900万米ドル、2026年には81億2000万米ドルに達する見通しで、また2021~2026年のCAGRは7.28%と予測されています。

当レポートでは、世界の膵臓がん診断の市場について分析し、業界の基本構造や背景事情・最新情勢、全体的な市場動向の見通し (過去・今後6年間分)、種類別・用途別・地域別の詳細動向、企業間の競争状態 (市場シェア構造)、主要企業のプロファイルと業績動向などについて調査しております。

目次

第1章 レポートの概要

  • 分析範囲
  • 種類別の市場分析
    • 世界の膵臓がん診断の市場規模・成長率:種類別 (2019/2020/2026年)
    • 画像診断 (イメージング)
    • 腫瘍バイオマーカー
    • 生検
  • 用途別の市場
    • 世界の膵臓がん診断の市場規模・シェア:用途別 (2019/2020/2026年)
    • 病院
    • クリニック
  • 分析対象
  • 分析期間

第2章 世界市場の成長動向

  • 世界の膵臓がん診断市場の将来展望 (2015~2026年)
  • 膵臓がん診断市場の成長動向:地域別
    • 膵臓がん診断の市場規模:地域別 (2019/2020/2026年)
    • 市場規模、実績値:地域別 (2015~2020年)
    • 市場規模、予測値:地域別 (2021~2026年)
  • 膵臓がん診断業界のダイナミック
    • 市場動向
    • 市場促進要因
    • 市場の課題
    • 市場抑制要因

第3章 主要企業間の競合情勢

  • 世界の膵臓がん診断の主要企業:市場規模
    • 市場収益額:主要企業別 (2019~2020年)
    • 市場収益額シェア:主要企業別 (2019~2020年)
  • 市場シェア:企業の種類別 (ティア1、ティア2、ティア3)
  • 分析対象企業:収益額ランキング
  • 膵臓がん診断市場の集中度
    • 市場集中度 (上位5社分、HHI指数)
    • 上位3社・5社の市場収益額 (2019年)
  • 主要企業の本社所在地
  • 主要企業の創立年度
  • 企業合併・買収 (M&A)/事業拡張計画

第4章 膵臓がん診断市場:種類別の詳細データ

  • 市場規模、実績値:種類別 (2015~2020年)
  • 市場規模、予測値:種類別 (2021~2026年)

第5章 膵臓がん診断市場:用途別の詳細データ

  • 市場規模、実績値:用途別 (2015~2020年)
  • 市場規模、予測値:用途別 (2021~2026年)

第6章 北米

  • 市場規模(2015~2026年)
  • 市場規模、実績値:種類別 (2015~2020年)
  • 市場規模、実績値:用途別 (2015~2020年)
  • 市場規模、実績値:国別 (2015~2020年)
    • 米国
    • カナダ
    • メキシコ

第7章 欧州

  • 市場規模、実績値:国別 (2015~2020年)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • 市場規模、実績値:国別 (2015~2020年)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 南米

第10章 中東・アフリカ

  • 市場規模、実績値:国別 (2015~2020年)
    • 中東
    • アフリカ

第11章 企業プロファイル:膵臓がん診断事業の主要指標

  • Siemens
  • GE Healthcare
  • Roche
  • Philips Healthcare
  • Danaher
  • キヤノンメディカルシステムズ
  • Abbott
  • 日立製作所 ヘルスケア
  • Qiagen
  • Myriad Genetics

第12章 アナリストの見解/結論

第13章 付録

図表

List of Tables and Figures

  • Table 1. Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type (M USD): 2019 VS 2020 VS 2026
  • Table 2. Global Pancreatic Cancer Diagnostic Market Size Growth by Application (M USD): 2019 VS 2020 VS 2026
  • Table 3. Global Pancreatic Cancer Diagnostic Market Size by Regions (M USD): 2019 VS 2020 VS 2026
  • Table 4. Global Pancreatic Cancer Diagnostic Market Size by Regions (2015-2020) & (M USD)
  • Table 5. Global Pancreatic Cancer Diagnostic Market Share by Regions (2015-2020)
  • Table 6. Global Pancreatic Cancer Diagnostic Forecasted Market Size by Regions (2021-2026) & (M USD)
  • Table 7. Global Pancreatic Cancer Diagnostic Market Share by Regions (2021-2026)
  • Table 8. Pancreatic Cancer Diagnostic Market Trends
  • Table 9. Pancreatic Cancer Diagnostic Market Drivers
  • Table 10. Pancreatic Cancer Diagnostic Market Challenges
  • Table 11. Pancreatic Cancer Diagnostic Market Restraints
  • Table 12. Global Pancreatic Cancer Diagnostic Revenue by Players (2019-2020) & (M USD)
  • Table 13. Global Pancreatic Cancer Diagnostic Market Share by Players (2019-2020)
  • Table 14. Global Top Pancreatic Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pancreatic Cancer Diagnostic as of 2019)
  • Table 15. Ranking of Global Top Pancreatic Cancer Diagnostic Manufacturers by Revenue (M USD) in 2019
  • Table 16. Global 5 Largest Players Market Share by Pancreatic Cancer Diagnostic Revenue (CR5 and HHI) & (2019-2020)
  • Table 17. Key Players Pancreatic Cancer Diagnostic Headquarter
  • Table 18. Establishment Year of Key Pancreatic Cancer Diagnostic Manufacturers
  • Table 19. Mergers & Acquisitions, Expansion Plans
  • Table 20. Global Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) & (M USD)
  • Table 21. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2015-2020)
  • Table 22. Global Pancreatic Cancer Diagnostic Forecasted Market Size by Type (2021-2026) & (M USD)
  • Table 23. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2021-2026)
  • Table 24. Global Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) & (M USD)
  • Table 25. Global Pancreatic Cancer Diagnostic Revenue Market Share by Application (2015-2020)
  • Table 26. Global Pancreatic Cancer Diagnostic Forecasted Market Size by Application (2021-2026) & (M USD)
  • Table 27. Global Pancreatic Cancer Diagnostic Revenue Market Share by Application (2021-2026)
  • Table 28. North America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) & (M USD)
  • Table 29. North America Pancreatic Cancer Diagnostic Market Share by Type (2015-2020)
  • Table 30. North America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) & (M USD)
  • Table 31. North America Pancreatic Cancer Diagnostic Market Share by Application (2015-2020)
  • Table 32. North America Pancreatic Cancer Diagnostic Market Size by Country (2015-2020) & (M USD)
  • Table 33. North America Pancreatic Cancer Diagnostic Market Share by Country (2015-2020)
  • Table 34. Europe Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) & (M USD)
  • Table 35. Europe Pancreatic Cancer Diagnostic Market Share by Type (2015-2020)
  • Table 36. Europe Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) & (M USD)
  • Table 37. Europe Pancreatic Cancer Diagnostic Market Share by Application (2015-2020)
  • Table 38. Europe Pancreatic Cancer Diagnostic Market Size by Country (2015-2020) & (M USD)
  • Table 39. Europe Pancreatic Cancer Diagnostic Market Share by Country (2015-2020)
  • Table 40. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) & (M USD)
  • Table 41. Asia-Pacific Pancreatic Cancer Diagnostic Market Share by Type (2015-2020)
  • Table 42. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) & (M USD)
  • Table 43. Asia-Pacific Pancreatic Cancer Diagnostic Market Share by Application (2015-2020)
  • Table 44. Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Country (2015-2020) & (M USD)
  • Table 45. Asia-Pacific Pancreatic Cancer Diagnostic Market Share by Country (2015-2020)
  • Table 46. South America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) & (M USD)
  • Table 47. South America Pancreatic Cancer Diagnostic Market Share by Type (2015-2020)
  • Table 48. South America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) & (M USD)
  • Table 49. South America Pancreatic Cancer Diagnostic Market Share by Application (2015-2020)
  • Table 50. South America Pancreatic Cancer Diagnostic Market Size by Country (2015-2020) & (M USD)
  • Table 51. South America Pancreatic Cancer Diagnostic Market Share by Country (2015-2020)
  • Table 52. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2015-2020) & (M USD)
  • Table 53. Middle East & Africa Pancreatic Cancer Diagnostic Market Share by Type (2015-2020)
  • Table 54. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2015-2020) & (M USD)
  • Table 55. Middle East & Africa Pancreatic Cancer Diagnostic Market Share by Application (2015-2020)
  • Table 56. Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country (2015-2020) & (M USD)
  • Table 57. Middle East & Africa Pancreatic Cancer Diagnostic Market Share by Country (2015-2020)
  • Table 58. Siemens Corporation Information
  • Table 59. Siemens Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 60. GE Healthcare Corporation Information
  • Table 61. GE Healthcare Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 62. Roche Corporation Information
  • Table 63. Roche Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 64. Philips Healthcare Corporation Information
  • Table 65. Philips Healthcare Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 66. Danaher Corporation Information
  • Table 67. Danaher Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 68. Canon Medical Systems Corporation Information
  • Table 69. Canon Medical Systems Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 70. Abbott Corporation Information
  • Table 71. Abbott Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 72. Hitachi Medical Corporation Information
  • Table 73. Hitachi Medical Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 74. Qiagen Corporation Information
  • Table 75. Qiagen Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 76. Myriad Genetics Corporation Information
  • Table 77. Myriad Genetics Pancreatic Cancer Diagnostic Revenue (M USD) and Gross Margin (2019-2020)
  • Table 78. Research Programs/Design for This Report
  • Table 79. Key Data Information from Secondary Sources
  • Table 80. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Pancreatic Cancer Diagnostic Market Share by Type: 2020
  • Figure 2. Global Pancreatic Cancer Diagnostic Market Share by Type: 2026
  • Figure 3. Imaging Features
  • Figure 4. Global Pancreatic Cancer Diagnostic Market Share by Application: 2026
  • Figure 5. Global Pancreatic Cancer Diagnostic Market Share by Application: 2020
  • Figure 6. Hospitals Case Studies
  • Figure 7. Clinics Case Studies
  • Figure 8. Pancreatic Cancer Diagnostic Report Years Considered
  • Figure 9. Global Pancreatic Cancer Diagnostic Market Size (M USD), Year-over-Year: 2015-2026
  • Figure 10. Global Pancreatic Cancer Diagnostic Market Size (M USD), 2015 VS 2020 VS 2026
  • Figure 11. Global Pancreatic Cancer Diagnostic Market Share by Regions: 2020
  • Figure 12. Global Pancreatic Cancer Diagnostic Market Share by Regions: 2026
  • Figure 13. Global Pancreatic Cancer Diagnostic Market Share by Regions (2021-2026)
  • Figure 14. Global Pancreatic Cancer Diagnostic Market Share by Players in 2019
  • Figure 15. The Top 3 Players Market Share by Pancreatic Cancer Diagnostic Revenue in 2019
  • Figure 16. The Top 5 Players Market Share by Pancreatic Cancer Diagnostic Revenue in 2019
  • Figure 17. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2015-2020)
  • Figure 18. Global Pancreatic Cancer Diagnostic Revenue Market Share by Type (2021-2026)
  • Figure 19. Global Pancreatic Cancer Diagnostic Revenue Market Share by Application (2015-2020)
  • Figure 20. Global Pancreatic Cancer Diagnostic Revenue Market Share by Application (2021-2026)
  • Figure 21. North America Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 22. United States Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 23. Canada Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 24. Mexico Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 25. Europe Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 26. Germany Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 27. France Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 28. U.K. Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 29. Italy Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 30. Russia Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 31. Asia-Pacific Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 32. China Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 33. Japan Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 34. Korea Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 35. Southeast Asia Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 36. India Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 37. Australia Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 38. South America Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 39. Brazil Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 40. Middle East & Africa Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 41. Middle East Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 42. Africa Pancreatic Cancer Diagnostic Market Size YoY Growth (2015-2026) & (M USD)
  • Figure 43. Siemens Pancreatic Cancer Diagnostic Product Information
  • Figure 44. GE Healthcare Pancreatic Cancer Diagnostic Product Information
  • Figure 45. Pancreatic Cancer Diagnostic Product Information of Roche
  • Figure 46. Philips Healthcare Pancreatic Cancer Diagnostic Product Information
  • Figure 47. Danaher Pancreatic Cancer Diagnostic Product Information
  • Figure 48. Canon Medical Systems Pancreatic Cancer Diagnostic Product Information
  • Figure 49. Abbott Pancreatic Cancer Diagnostic Product Information
  • Figure 50. Hitachi Medical Pancreatic Cancer Diagnostic Product Information
  • Figure 51. Qiagen Pancreatic Cancer Diagnostic Product Information
  • Figure 52. Myriad Genetics Pancreatic Cancer Diagnostic Product Information
  • Figure 53. Bottom-up and Top-down Approaches for This Report
  • Figure 54. Data Triangulation
  • Figure 55. Key Executives Interviewed
目次

Market Analysis and Insights: Global Pancreatic Cancer Diagnostic Market

The global Pancreatic Cancer Diagnostic market size is projected to reach US$ 8120 million by 2026, from US$ 5129 million in 2019, at a CAGR of 7.28% during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pancreatic Cancer Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pancreatic Cancer Diagnostic market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pancreatic Cancer Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pancreatic Cancer Diagnostic market.

Global Pancreatic Cancer Diagnostic Scope and Segment

Pancreatic Cancer Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Cancer Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

By Company

Siemens

GE Healthcare

Roche

Philips Healthcare

Danaher

Canon Medical Systems

Abbott

Hitachi Medical

Qiagen

Myriad Genetics

Segment by Type

  • Imaging
  • Tumor Biomarker
  • Biopsy
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • South America
  • Brazil
  • Middle East & Africa
  • Middle East
  • Africa

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type: 2019 VS 2020 VS 2026
    • 1.2.2 Imaging
    • 1.2.3 Tumor Biomarker
    • 1.2.4 Biopsy
  • 1.3 Market by Application
    • 1.3.1 Global Pancreatic Cancer Diagnostic Market Share by Application: 2019 VS 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global Pancreatic Cancer Diagnostic Market Perspective (2015-2026)
  • 2.2 Pancreatic Cancer Diagnostic Growth Trends by Regions
    • 2.2.1 Pancreatic Cancer Diagnostic Market Size by Regions: 2019 VS 2020 VS 2026
    • 2.2.2 Pancreatic Cancer Diagnostic Historic Market Size by Regions (2015-2020)
    • 2.2.3 Pancreatic Cancer Diagnostic Forecasted Market Size by Regions (2021-2026)
  • 2.3 Pancreatic Cancer Diagnostic Industry Dynamic
    • 2.3.1 Pancreatic Cancer Diagnostic Market Trends
    • 2.3.2 Pancreatic Cancer Diagnostic Market Drivers
    • 2.3.3 Pancreatic Cancer Diagnostic Market Challenges
    • 2.3.4 Pancreatic Cancer Diagnostic Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 Global Top Pancreatic Cancer Diagnostic Players by Market Size
    • 3.1.1 Global Top Pancreatic Cancer Diagnostic Players by Revenue (2019-2020)
    • 3.1.2 Global Pancreatic Cancer Diagnostic Revenue Market Share by Players (2019-2020)
  • 3.2 Global Pancreatic Cancer Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pancreatic Cancer Diagnostic Revenue
  • 3.4 Global Pancreatic Cancer Diagnostic Market Concentration Ratio
    • 3.4.1 Global Pancreatic Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 3 and Top 5 Companies by Pancreatic Cancer Diagnostic Revenue in 2019
  • 3.5 Key Players Pancreatic Cancer Diagnostic Headquarter
  • 3.6 Establishment Year of Key Pancreatic Cancer Diagnostic Manufacturers
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 PANCREATIC CANCER DIAGNOSTIC BREAKDOWN DATA BY TYPE

  • 4.1 Global Pancreatic Cancer Diagnostic Historic Market Size by Type (2015-2020)
  • 4.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Type (2021-2026)

5 PANCREATIC CANCER DIAGNOSTIC BREAKDOWN DATA BY APPLICATION

  • 5.1 Global Pancreatic Cancer Diagnostic Historic Market Size by Application (2015-2020)
  • 5.2 Global Pancreatic Cancer Diagnostic Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

  • 6.1 North America Pancreatic Cancer Diagnostic Market Size (2015-2026)
  • 6.2 North America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020)
  • 6.3 North America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020)
  • 6.4 North America Pancreatic Cancer Diagnostic Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada
    • 6.4.3 Mexico

7 EUROPE

  • 7.1 Europe Pancreatic Cancer Diagnostic Market Size (2015-2026)
  • 7.2 Europe Pancreatic Cancer Diagnostic Market Size by Type (2015-2020)
  • 7.3 Europe Pancreatic Cancer Diagnostic Market Size by Application (2015-2020)
  • 7.4 Europe Pancreatic Cancer Diagnostic Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Pancreatic Cancer Diagnostic Market Size (2015-2026)
  • 8.2 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Pancreatic Cancer Diagnostic Market Size by Country (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 SOUTH AMERICA

  • 9.1 South America Pancreatic Cancer Diagnostic Market Size (2015-2026)
  • 9.2 South America Pancreatic Cancer Diagnostic Market Size by Type (2015-2020)
  • 9.3 South America Pancreatic Cancer Diagnostic Market Size by Application (2015-2020)
  • 9.4 South America Pancreatic Cancer Diagnostic Market Size by Country (2015-2020)

10 MIDDLE EAST & AFRICA

  • 10.1 Middle East & Africa Pancreatic Cancer Diagnostic Market Size (2015-2026)
  • 10.2 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Country (2015-2020)
    • 10.4.1 Middle East
    • 10.4.2 Africa

11 COMPANY PROFILES AND KEY FIGURES IN PANCREATIC CANCER DIAGNOSTIC BUSINESS

  • 11.1 Siemens
    • 11.1.1 Siemens Corporation Information
    • 11.1.2 Siemens Product Information
    • 11.1.3 Siemens Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.2 GE Healthcare
    • 11.2.1 GE Healthcare Corporation Information
    • 11.2.2 GE Healthcare Product Information
    • 11.2.3 GE Healthcare Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.3 Roche
    • 11.3.1 Roche Corporation Information
    • 11.3.2 Product Information
    • 11.3.3 Roche Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.4 Philips Healthcare
    • 11.4.1 Philips Healthcare Corporation Information
    • 11.4.2 Philips Healthcare Product Information
    • 11.4.3 Philips Healthcare Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.5 Danaher
    • 11.5.1 Danaher Corporation Information
    • 11.5.2 Danaher Product Information
    • 11.5.3 Danaher Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.6 Canon Medical Systems
    • 11.6.1 Canon Medical Systems Corporation Information
    • 11.6.2 Canon Medical Systems Product Information
    • 11.6.3 Canon Medical Systems Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.7 Abbott
    • 11.7.1 Abbott Corporation Information
    • 11.7.2 Abbott Product Information
    • 11.7.3 Abbott Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.8 Hitachi Medical
    • 11.8.1 Hitachi Medical Corporation Information
    • 11.8.2 Hitachi Medical Product Information
    • 11.8.3 Hitachi Medical Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.9 Qiagen
    • 11.9.1 Qiagen Corporation Information
    • 11.9.2 Qiagen Product Information
    • 11.9.3 Qiagen Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)
  • 11.10 Myriad Genetics
    • 11.10.1 Myriad Genetics Corporation Information
    • 11.10.2 Myriad Genetics Product Information
    • 11.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Revenue and Gross Margin (2019-2020)

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.